Gamma Investing LLC Argenx Se Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Argenx Se stock. As of the latest transaction made, Gamma Investing LLC holds 135,538 shares of ARGX stock, worth $80.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,538
Previous 252
53684.92%
Holding current value
$80.2 Million
Previous $155 Million
99.85%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
434Shares Held
28.8MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.27 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.82 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.37 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.06 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$733 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...